Counteracting negative venous line pressures to avoid arterial air bubbles: an experimental study comparing two different types of miniaturized extracorporeal perfusion systems by Anas Aboud et al.
RESEARCH ARTICLE Open Access
Counteracting negative venous line pressures
to avoid arterial air bubbles: an experimental
study comparing two different types of
miniaturized extracorporeal perfusion systems
Anas Aboud1*, Hendrikje Mederos-Dahms1, Kai Liebing2, Armin Zittermann1, Harald Schubert3, Edward Murray1,
Andre Renner1, Jan Gummert1 and Jochen Börgermann1
Abstract
Background: Because of its low rate of clinical complications, miniaturized extracorporeal perfusion systems (MEPS)
are frequently used in heart centers worldwide. However, many recent studies refer to the higher probability of
gaseous microemboli formation by MEPS, caused by subzero pressure values. This is the main reason why various
de-airing devices were developed for today’s perfusion systems. In the present study, we investigated the potential
benefits of a simple one-way-valve connected to a volume replacement reservoir (OVR) for volume and pressure
compensation.
Methods: In an experimental study on 26 pigs, we compared MEPS (n = 13) with MEPS plus OVR (n = 13). Except
OVR, perfusion equipment was identical in both groups. Primary endpoints were pressure values in the venous line
and the right atrium as well as the number and volume of air bubbles. Secondary endpoints were biochemical
parameters of systemic inflammatory response, ischemia, hemodilution and hemolysis.
Results: One animal was lost in the MEPS +OVR group. In the MEPS +OVR group no pressure values below −150 mmHg
in the venous line and no values under -100 mmHg in right atrium were noticed. On the contrary, nearly 20 % of venous
pressure values in the MEPS group were below −150 and approximately 10 % of right atrial pressure values were
below -100 mmHg. Compared with the MEPS group, the bubble counter device showed lower numbers of arterial
air bubbles in the MEPS + OVR group (mean ± SD: 13444 ± 5709 vs. 1 ± 2, respectively; p < 0.001). In addition,
bubble volume was significantly lower in the MEPS + OVR group than in the MEPS group (mean ± SD: 1522 ±
654 μl vs. 4 ± 6 μl, respectively; p < 0.001). The proinflammatory cytokine interleukin-6 and biochemical indices of
cardiac ischemia (creatine kinase, and troponin I) were comparable between both groups.
Conclusions: The use of a miniaturized perfusion system with a volume replacement reservoir is able to counteract
excessive negative venous line pressures and to reduce the number and volume of arterial air bubbles. This approach
may lead to a lower rate of neurological complications.
Keywords: Miniaturized extracorporeal perfusion system, One-way-valve, Gaseous microembolism, Excessive negative
venous line pressure, Systemic inflammatory response
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Background
The clinical advantages of miniaturized extracorporeal
perfusion systems (MEPS) are well accepted. In addition
to decreasing the inflammatory response, miniaturized
closed-circuit perfusion systems limit the amount of he-
modilution and transfusion requirements [1]. A reduced
foreign surface contact area, elimination of blood/air
interface by omitting the venous reservoir, and a lower
priming volume are some of the reasons for these bene-
fits [1]. A recent study of our research group has con-
firmed these advantages [2]. However, we also showed
that omitting the venous reservoir is associated with ex-
cessive negative venous line pressures and a significant
increase in the number and volume of arterial air bub-
bles compared with conventional cardiopulmonary by-
pass (CCPB), unless specific de-airing safety procedures
are introduced. Similar results were reported by Norman
et al. [3]. Air bubbles may result in strokes and neuro-
psychological deficits [4, 5]. Excessive subzero pressures
occur mainly due to suction phenomena under volume
depletion [2]. When the venous line reservoir is removed
in minimized systems, the perfusionist cannot counter-
act an insufficient venous return by adding reservoir
blood, a technique commonly used with CCPB. To avoid
this problem, we have developed a new one-way-valve at
the venous line connected to a volume replacement res-
ervoir (OVR) [6]. In the present study, we included this
device in a closed perfusion system without any applica-
tion of an extra air removal device. The present study
aimed to investigate the effects of MEPS with or without
OVR on pressure values in the venous line and right
atrium. We compared the pressure differences as well as
the volume and number of air bubbles in the two perfu-
sion systems. The overall goal of this work was to in-
crease the safety of minimized perfusion systems by




The study was carried out in 26 healthy pigs weighing
55–65 kg. The animals were kept in accordance with the
German national standards on laboratory animal welfare.
All experiments performed in this study were approved
by the local ethics committee on animal research of the
State of Thuringia and conducted at the animal labora-
tory of the Friedrich Schiller University Jena, Germany.
The study was supported by a grant from the German
Heart Foundation.
Anesthesia protocol
The animals were pre-medicated with intramuscular keta-
mine (10 mg/kg body weight [BW]) and midazolam
(0.5 mg/kg BW) and subsequently endotracheally intubated.
Inhalation anesthesia was maintained with 1–2 % isoflurane.
After an initial intravenous dose of fentanyl (0.1 mg) and
pancuronium (1 mg), additional doses were administered as
needed. Volume-controlled ventilation was maintained at a
frequency of 14/min, a tidal volume of 6–8 mL/kg BW, and
a positive end-expiratory pressure of 5 mbar. The inspired
oxygen fraction was kept constant at 0.5. A right carotid
artery catheter was inserted for blood pressure and blood
gas monitoring. In addition, a central venous catheter was
inserted through the right external jugular vein. At the end
of the experiments, all animals were euthanized with a po-
tassium chloride overdose while in deep anesthesia. This
conforms with the German regulations on animal studies.
Surgical technique
All surgical procedures were carried out under sterile con-
ditions. After instituting hemodynamic monitoring, a ster-
notomy was performed. A 300 IU/kg BW heparin bolus
was administered. The cardiopulmonary bypass was pre-
pared by inserting a 40–32 F dual-stage venous cannula
(Sorin, Munich, Germany) through the right atrial append-
age into the inferior vena cava and a 21 F aortic cannula
(Maquet Cardiopulmonary AG, Hirrlingen, Germany) into
the ascending aorta. Normothermic extracorporeal perfu-
sion was commenced and maintained for 3 hours in all
experiments.
In order to investigate the differences between the
two perfusion groups not only during the circulating of
the pump, but also throughout real circumstances and
during operative manipulations, diastolic cardiac arrest
was achieved 2 hours after the initiation of the extracor-
poreal perfusion by clamping the ascending aorta and
by instilling intermittent doses of antegrade warm blood
cardioplegia (Calafiore) into the aortic root. In all pigs,
the left internal mammary artery was anastomosed to
the left anterior descending coronary artery. The X-
clamp time was 30 min. After removal of the aortic
clamp and after 10 min of reperfusion, the animals were
weaned from cardiopulmonary bypass. Subsequently,
the cannulas were removed and the heparin effect was
reversed with a matched protamine dose. This was
followed by 15 min of post-perfusion observation.
Study design
The animals were allocated to either MEPS with OVR (des-
ignated MEPS +OVR) or MEPS without OVR (designated
MEPS). On each experimental day, one or two animals
were randomly operated on with the same technique. Study
duration was from May 2007 until June 2009. We lost one
animal in the MEPS +OVR group during initiation of
anesthesia. At the end of the study, data assessment was
possible in 13 animals in the MEPS group and in 12
animals in the MEPS + OVR group. Primary study end-
points were pressure values and the number and volume
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of air bubbles. Secondary endpoints were biochemical
parameters.
Perfusion systems
The MEPS circuit (Fig. 1) is a fully heparinized closed
perfusion System with a high-performance hollow fiber
membrane oxygenator (HILITE® 7000, MEDOS Medi-
zintechnik AG, Stolberg, Germany) with a maximum
flow rate of 7 l/min. The surface area for gas exchange
is 1.9 m2 and the priming volume 275 ml. In addition, a
centrifugal pump (DELTASTREAM DP2; MEDOS
Medizintechnik AG, Stolberg, Germany) was used. A
console (DELTASTREAM Driving Console, MEDOS
Medizintechnik AG, Stolberg, Germany) provided man-
ual control, adjustment and surveillance of pump func-
tion. The automatic pump speed regulator of the device
was not used. Pump priming volume is 17 mL, pump
speed 100–10,000 rpm, and flow capacity 0–8 l/min.
We used the same heparin coated arterial filter (SEN-
TRY, Sorin Group, Munich, Germany) with a minimum
priming volume and a simple debubbling system in all
experiments. Phosphorylcholine coated tubing (PVC
Tubing, Sorin Group, Munich, Germany) was used. The
tubing length was less than 200 cm. This setup with a
total priming volume of approximately 450 ml (275 ml
oxygenator, 17 ml arterial line filter, approximately
142 ml tubing) has a small blood/foreign surface contact
area and results in low hemodilution. The MEPS prim-
ing fluid was made up of ringer solution (180 mL), 6 %
hydroxyethyl starch (180 mL), mannitol (90 mL), and
heparin (5000 IU).
The construction of a miniaturized extracorporeal per-
fusion system with automatic compensation of pressure
and volume changes was patented in Germany in 2005
[7]. The perfusion system we used in the present study
was based on this patent. For our study, we used different
components provided by different companies. In addition
to the MEPS, the perfusion system in the MEPS +OVR
group included a standard hard-shell reservoir (HILITE,
MEDOS Medizintechnik AG, Stolberg, Germany), which
was used to substitute volume when required (Fig. 2). This
reservoir was filled with Ringer solution (500 mL) and 6 %
hydroxyethyl starch (500 mL). An additional component
was integrated into the circuit: A one-way-valve posi-
tioned between the outflow of the reservoir and the cen-
trifugal pump, allowing flow from the reservoir towards
the pump. As a one-way-valve we use in this study the saf-
tey silicone valve (Retroguard ® 4007100,Quest Medical,
Inc.) with a priming volume of approximately 10 ml. This
valve is typically used for other applications. In our sys-
tem, however, the valve acts as a safeguard against exces-
sive negative pressure by automatically opening when the
pressure in the venous segment of the circuit drops below
values between −75 and −90 mmHg. Thereby, volume
from the primed reservoir compensates for low negative
pressures [6].
In both groups, the composition of the priming vol-
ume and all equipment (oxygenator, centrifugal pump,
arterial filter and tubing) was identical. There was a
standard perfusion protocol for both groups with target
arterial pressures of 50–60 mmHg and pump flows of
65–75 ml/kg/min BW. The volume management during
Fig. 1 Graphical illustration of the miniaturized extracorporeal perfusion system
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the extracorporeal perfusion was controlled by the per-
fusionist in depending on requirement in order to have
pump flow values constant in the target area. The sub-
stituation was done automatically from the connected
reservoir in the MEPS + OVR group and over the cen-
tral venous catheter in the MEPS group.
Study procedures
During extracorporeal perfusion, right atrial pressure
was monitored with a catheter (LAP 1751, Maquet Car-
diopulmonary AG, Hirrlingen, Germany). Additionally,
the venous line pressure was measured. All pressure
values were digitized in 250 ms intervals using a modi-
fied analog-to-digital converter and special software de-
veloped by the Department of Medical Technology at
the University of Jena.
Microbubbles were measured and analyzed with the
BCC200 system (GAMPT GmbH, Zapfendorf, Germany),
which is certified for clinical use. This system counts
micro-bubbles and determines their size and volume,
depicting the results in a histogram. The venous and
arterial lines of the extracorporeal circuit were moni-
tored with two independent sensors. In order to detect
bubbles in the venous blood from the right atrium, the
venous sensor was directly placed on the venous line at
a point before the line connects with the perfusion sys-
tem. For the arterial sensor, we chose a position on the
arterial line after the arterial filter to detect air bubbles
entering the aorta.
We also collected blood samples before extracorporeal
circuit (t0), 10 min (t1), 60 min (t2), and 120 min (t3) after
commencing extracorporeal circuit. An additional sample
was collected immediately after extracorporeal circuit
Fig. 2 Graphical illustration of the miniaturized extracorporeal perfusion system plus volume replacement reservoir
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termination (t4). The following parameters were mea-
sured: blood gases, hemoglobin, hematocrit, lactate dehy-
dogenase, free hemoglobin, bilirubin, interleukin 6 (IL-6),
troponin I and creatine kinase.
Statistics
Approximately 28,000 (27332 +/− 3529) arterial and
venous pressure values were analyzed per animal. It was
of particular interest to assess the percentage of very low
negative pressures values in the right atrium and the
venous line rather than mean pressure values. Therefore,
values were categorized into 7 (right atrium values) and
5 (venous line values) pressure bins. The percentage of
observations in each pressure group was assessed. For
the statistical analysis, these values were treated as con-
tinuous variables. We also documented in this study the
numbers of gaseous microemboli and their volume dur-
ing extracorporeal circuit time. The pressure value per-
centages in each category and the air bubble numbers
and volumes were analyzed using the unpaired t-test. A
two-factor repeated-measures analysis of variance was
used to assess time effects and to analyze time x treat-
ment (type of perfusion system) interaction effects on all
dependent biochemical variables. Since several biochem-
ical parameters such as leucocytes, IL-6, and bilirubin
were not normally distributed, these biochemical data
were logarithmically transformed to achieve almost
normally distributed data. All continuous variables were
expressed as mean and standard deviation (SD). P values <
0.05 were considered significant. We used the statistical
software package SPSS, version 20 (IBM Corp, Armonk,
NY, USA), to perform the analyses.
Results
Primary endpoints
The percentage of venous line and right atrial pressures in
each pressure category is presented in Table 1. Compared
with the MEPS group, the pressure values in the venous
line as well as in the right atrium were significantly higher
in the MEPS +OVR group: Approximately 80 % of venous
pressure values were above −50 mmHg and only a few
values were between −75 and −149 mmHg in the MEPS +
OVR group. No values below −150 mm Hg were
observed. Low pressure values occurred much more fre-
quently in the MEPS group. Nearly 20 % of venous pres-
sure values were below −150 mmHg and approximately
30 % of right atrial pressure values were below −30 mmHg
in the MEPS group, 9.5 % were below −100 mmHg. The
low pressure values in the MEPS group were accompanied
by a much higher number of arterial and venous air bub-
bles than in the MEPS +OVR group (Fig. 3). In detail, the
number of air bubbles in the arterial line was 13444 ±
5709 vs. 1 ± 2 (p < 0.001), and 16640 ± 16070 vs. 49 ± 60
(p < 0.001) in the venous line. In addition, the volume of
the arterial and venous bubbles was much higher during
MEPS than during MEPS +OVR (Fig. 4). Arterial air bub-
bles during MEPS and MEPS +OVR had a volume of
1522 ± 654 μl and 4 ± 6 μl, respectively (p < 0.001). Venous
air bubbles had a volume of 1683 ± 1322 μl during MEPS
vs. 21 ± 52 μl during MEPS +OVR (p < 0.001).
Secondary endpoints
The time courses of the measured biochemical parame-
ters are illustrated in Figs. 5, 6 and 7. During the pro-
cedure, hemoglobin and hematocrit values decreased
significantly in both study groups (p < 0.001). In con-
trast, free hemoglobin values increased markedly (p <
0.001). Compared with the MEPS group, hemoglobin
and hematocrit values remained higher in the MEPS +
OVR group (p = 0.0013 and p = 0.016, respectively). The
increase in free hemoglobin was more pronounced in
the MEPS + OVR group than in the MEPS group (p =
0.017). There was a time-dependent decrease in leuco-
cyte counts (p < 0.001), whereas IL-6 concentrations in-
creased during the study (p = 0.026). However, these
changes did not differ between study groups. The
increase in bilirubin was less pronounced in the MEPS +
OVR group compared with the MEPS group (p = 0.044).
Changes in biochemical indicators of cardiac ischemia
such as lactate dehydrogenase, creatine kinase, and tropo-
nin I were comparable between study groups (p > 0.05).
Discussion
This study tested a newly developed device located at
the venous side of the MEPS for automatic compensa-
tion of pressure and volume changes. Upgrading the
Table 1 Venous and arterial line pressure distribution according
to study group
MEPS + OVR group MEPS group P value
Venous line pressure (%)
> −50 mmHg 85.7 ± 13.3 23.2 ± 20.5 <0.001
−50 to −74 mmHg 12.4 ± 11.7 37.8 ± 24.1 <0.001
−75 to −149 mmHg 1.9 ± 5.1 18.9 ± 12.0 <0.001
−150 to −299 mmHg 0 16.9 ± 11.3 <0.001
≤ − 300 mmHg 0 2.1 ± 2.1 0.006
Right arterial line pressure (%)
>10 mmHg 3.2 ± 4.8 1.2 ± 0.9 0.664
10 to 1 mmHg 56.4 ± 7.6 17.2 ± 14.0 <0.001
0 to −9 mmHg 37.8 ± 12.0 31.7 ± 12.7 0.902
−10 to −29 mmHg 2.3 ± 0.7 18.1 ± 17.0 0.014
−30 to −99 mmHg 0.4 ± 0.3 21.1 ± 6.5 <0.001
−100 to −199 mmHg 0 9.5 ± 3.7 <0.001
≤ − 200 mmHg 0 1.2 ± 0.4 <0.001
MEPS miniaturized extracorporeal perfusion system; MEPS + OVR miniaturized
extracorporeal perfusion system plus volume replacement reservoir group
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MEPS requires little effort and minimum costs. The up-
grade avoids shortcomings such as the excessive nega-
tive venous line pressures and increased numbers and
volume of arterial air bubbles. Importantly, the benefits
of MEPS such as a reduced systemic inflammatory re-
sponse, and less hemodilution and hemolysis [1] are
preserved.
Many studies during the last years focused on the prob-
lem of gaseous microemboli during miniaturized extracor-
poreal circuit [8–11]. New de-airing devices were developed
to eliminate bubbles [9]. However, studies concentrated on
the elimination of already existing gaseous bubbles and not
on their avoidance. We [2] and others [12] have already
demonstrated that excessive negative pressures in the ven-
ous line play a major role in the production of gaseous
microemboli. The observed pressure differences were pri-
marily due to volume depletion and underline the need for
an appropriate and sensitive sensor for detecting it. Stand-
ard venous pressure monitoring is not always sensitive
enough to detect pressure differences [13]. Current auto-
matic pump flow controllers act as pressure regulators, but
with a delay. Under certain circumstances they are not fast
enough to sufficiently counteract negative pressure nadirs.
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Fig. 3 Mean number of gaseous microemboli in the arterial and venous line according to study group. ***P < 0.001 miniaturized extracorporeal





















Fig. 4 Mean volume of air bubbles in the arterial and venous line according to study group. ***P < 0.001 miniaturized extracorporeal perfusion
system plus volume replacement reservoir group vs. miniaturized extracorporeal perfusion system group
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reduction and thereby to decreased perfusion. Even an ex-
perienced perfusionist and anesthesiologist handling the
volume management very carefully cannot provide 100 %
safety.
To address the problem of excessive negative pressures,
we added a newly developed one-way-valve for automatic
pressure and volume compensation to the MEPS. This
valve is part of the Jena Universal Perfusion System [6].
Our study shows that the use of a one-way-valve limits ex-
cessive negative pressures, leading to a significantly re-
duced number and volume of gaseous emboli. This
observed positive effect depends mainly on the automatic
1 2 3 4 5
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Fig. 6 Time course of leucocytes (a), interleukin 6 (b), and bilirubin (c)
Aboud et al. BMC Anesthesiology  (2015) 15:81 Page 7 of 9
compensating mechanism of the one-way-valve. Volume
lost during surgery due to diuresis or bleeding would be
automatically replaced by a matched volume from the res-
ervoir when the one-way-valve opens. Timely volume re-
placement avoids excessive negative line pressures, leading
to comfortable operating circumstances with less stress to
the anesthesiologist and perfusionist.
Arterial line bubbles passing into the aorta may cause
postoperative neurological events such as stroke or transi-
tory psychotic syndrome [4]. Helps et al. [14] reported in
an experimental study in rabbits that arterial air emboli of
25 μl caused only transient changes in the cortical som-
atosensory evoked response, whereas bubbles > 400 μl
caused prolonged adverse effects. We therefore believe
that every effort should be taken to avoid air bubbles and
to increase the safety of all perfusion systems. Due to a re-
duced foreign surface area and avoidance of blood-air
contact, MEPS is associated with lower systemic inflam-
matory response than CCPB [1]. Pro-inflammatory cyto-
kines such as IL-6 increase in response to many major
surgical procedures as well as to cardiopulmnary bypass
[1]. In our study, circulating IL-6 levels did not differ be-
tween study groups. This may be due to the consistently
low levels of this proinflammatory cytokine from t0 to t3
and the large standard deviation at t4. It is also note-
worthy that biochemical indicators of cardiac ischemia
were identical in both groups. Although volume substitu-
tion was done automatically during one-way-valve use,
levels of hemoglobin and hematocrit stay slightly higher
than without one-way-valve. This may be due to easier
and more optimized volume management. To avoid suc-
tion phenomenon at the venous side during miniturized
perfusion system, there might be the tendency to substi-
tute more volume as needed, until the target pump flow is
achieved. Free hemoglobin and bilirubin differences be-
tween groups were small and probably of minor clinical
relevance.
The present study has limitations. Despite its clear re-
sults, it remains an experimental investigation with a
small number of cases. Clinical endpoints like postoper-
ative neurological or neurocognitive complications were
not considered. Randomized controlled trials are still
needed to compare the effect of different perfusion sys-
tems on neurological outcome.
Conclusions
Miniaturized perfusion systems can become safer by add-
ing a simple one-way-valve -connected to a volume re-
placement reservoir- to the venous side for automatic
pressure and volume compensation. With this novel ap-
proach, advantages of mini-systems such as less systemic
inflammatory response are preserved and disadvantages
such as excessive subzero pressures and gaseous microem-
boli can be avoided.
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